Room 4331, 3th building, high-tech industrial park, yizhi road, qingshan district, wuhan, China
Home ProductsAnti Estrogen Steroids

Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements

Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements

  • Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements
  • Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements
  • Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements
  • Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements
Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements
Product Details:
Place of Origin: Hubei, China
Brand Name: Bodybiological
Certification: ISO9001, SGS
Model Number: 129453-61-8
Payment & Shipping Terms:
Minimum Order Quantity: 10gram
Price: USD1/gram
Packaging Details: Foil bag
Delivery Time: within 24 hours after the payment
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 110kg/month
Contact Now
Detailed Product Description
Keywords: Fulvestrant CAS: 129453-61-8
Appearance: White Powder Shipping Method: FEDEX, TNT, DHL, UPS, HK EMS
Payment Terms: Money Gram, Western Union, Bank Transfer Export Market: USA, UK, Brazil, Thailand, Canada
MOQ: 10gram Purity: 99.5%
Policy: Reshipping Policy Brand: Bodybiological
High Light:

anti estrogen supplements

,

bodybuilding estrogen blocker

Treatment Receptor Fulvestrant CAS 129453-61-8 Anti Estrogen Steroids

 

whatsapp:+8613429837396

 

Basic information:

 

Product Name Fulvestrant Faslodex
Chemical Name Faslodex
CAS Number 129453-61-8
Molecular Formula C32H47F5O3S
Molecular Weight 606.77
Melting Point 104-106ºC
Assay 99.5%
Appearance White powder

 

Detailed information:

 

Fulvestrant, sold under the trade name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.[1] It is given by injection into a muscle.
Fulvestrant is a selective estrogen receptor degrader (SERD) and was first-in-class to be approved. It works by binding to the estrogen receptor and destabilizing it, causing the cell's normal protein degradation processes to destroy it.
Fulvestrant was approved for medical use in the United States in 2002.

 

Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer or locally advanced unresectable disease in postmenopausal women; it is given by injection. A 2017 Cochrane review found it is as safe and effective as first line or second line endocrine therapy.
It is also used to treat HR-positive, HER2-negative advanced or metastatic breast cancer in combination with palbociclib in women with disease progression after first-line endocrine therapy.
It should not be used in women with kidney failure or who are pregnant.
Due to the medication having a similar chemical structure to estrogen, it can interact with immunoassays for blood estradiol concentrations and show falsely elevated results. This can improperly lead to discontinuing the treatment.

 

Application:

 

Fulvestrant was studied in endometrial cancer but results were not promising and as of 2016 development for this use was abandoned.[15]
Because fulvestrant is a steroid and cannot be given orally, efforts have been made to develop SERD drugs that can be taken by mouth, including brilanestrant and elacestrant.[3] The clinical success of fulvestrant also led to efforts to discover and develop a parallel drug class of selective androgen receptor degraders (SARDs).

 

Function:

 

Have a low level of platelets in your blood or bleed easily. Especially tell your healthcare provider if you take a blood thinner medicine (anticoagulants)
Have liver problems
Are pregnant or plan to become pregnant, as FASLODEX can harm your unborn baby. Females who are able to become pregnant should use effective birth control during treatment with FASLODEX and for one year after the last dose. Tell your healthcare provider right away if you become pregnant or think you are pregnant while on FASLODEX
Are breast-feeding or plan to breast-feed. It is not known if FASLODEX passes into breast milk. Do not breast-feed during treatment with FASLODEX and for one year after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time.

 

Other related products:

 

Testosterone Acetate Trenbolone Acetate MGF
Testosterone Cypionate Trenbolone Enanthate PEG MGF
Testosterone Decanoate Boldenone Acetate CJC-1295
Testosterone Enanthate Boldenone undecylenate CJC-1295 DAC
Testosterone Isocaproate Boldenone Cypionate PT-141
TestosteronePhenylpropionate Boldenone Propionate Melanotan-1
Testosterone Propionate Nandrolone Decanoate Melanotan-2
Testosterone Undecanoate Nandrolone phenylpropionate GHRP-2
Mesterone Nandrolone undecylate GHRP-6
Testosterone Sustanon 250 Nandrolone cypionate Ipamorelin
Clostebol Acetate Nandrolone propionate Hexarelin
Methylandrostanolone Methyltrienolone Sermorelin
Methenolone Enanthate Drostanolone Propionate Oxytocin
Methenolone Acetate Drostanolone Enanthate TB500
Anadrol Stanolone Fragment 176-191
Anavar Tadalafil Triptorelin
Winstrol Vardenafil Tesamorelin
Clomifene citrate Dianabol Gonadorelin
Toremifene citrate   DSIP
Finasteride hydrochloride Selank

 

Treatment Receptor Fulvestrant Faslodex , CAS 129453-61-8 Anti Estrogen Supplements 0 

Contact Details
Wuhan Body Biological Co.,Ltd

Contact Person: Penny

Tel: +8613429837396

Send your inquiry directly to us (0 / 3000)

Other Products